Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1

Abstract

Programmed cell death, or apoptosis, is important in homeostasis of the immune system: for example, non-functional or auto-reactive lymphocytes are eliminated through apoptosis. One member of the tumour necrosis factor receptor (TNFR) family, Fas (also known as CD95 or Apo-1), can trigger cell death and is essential for lymphocyte homeostasis1,2. FADD/Mort1 (36) is a Fas-associated protein that is thought to mediate apoptosis by recruiting the protease caspase-8 (refs 7, 8). A dominant-negative mutant of FADD inhibits apoptosis initiated by Fas and other TNFR family members6,9,10,11,12,13,14. Other proteins, notably Daxx, also bind Fas and presumably mediate a FADD-independent apoptotic pathway15. Here we investigate the role of FADD in vivo by generating FADD-deficient mice. As homozygous mice die in utero, we generated FADD−/− embryonic stem cells and FADD−/− chimaeras in a background devoid of the recombination activating gene RAG-1, which activates rearrangement of the immunoglobulin and T-cell receptor genes. We found that thymocyte subpopulations were apparently normal in newborn chimaeras. Fas-induced apoptosis was completely blocked, indicating that there are no redundant Fas apoptotic pathways. As these mice age, their thymocytes decrease to an undetectable level, although peripheral T cells are present in all older FADD−/− chimaeras. Unexpectedly, activation-induced proliferation is impaired in these FADD−/− T cells, despite production of the cytokine interleukin (IL)-2. These results and the similarities between FADD−/− mice and mice lacking the β-subunit of the IL-2 receptor suggest that there is an unexpected connection between cell proliferation and apoptosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Targeted inactivation of the gene encoding FADD/Mort1 in ES cells and in mice.
Figure 2: Flow cytometric analysis of thymocytes from wild-type 129/Sv × B6, RAG-1−/−, FADD−/− to RAG-1−/− (FADD−/−), and FADD+/+ to RAG-1−/− (FADD+/+) mice.
Figure 3: Flow cytometric analysis of peripheral lymphocytes.
Figure 4: Fas-mediated cell death is blocked in the absence of FADD.
Figure 5: T-cell proliferation and death and IL-2 secretion assay.

Similar content being viewed by others

References

  1. Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449–1455 (1995).

    Article  ADS  CAS  Google Scholar 

  2. Matiba, B., Mariani, S. M. & Krammer, P. H. The CD95 system and the death of a lymphocyte. Semin. Immunol. 9, 59–68 (1997).

    Article  CAS  Google Scholar 

  3. Boldin, M. P.et al. Anovel protein that interacts with the death domain. J. Biol. Chem. 270, 7795–7798 (1995).

    Article  CAS  Google Scholar 

  4. Chinnaiyan, A. M., O'Rourke, K., Tewari, M. & Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505–512 (1995).

    Article  CAS  Google Scholar 

  5. Kischkel, F. C.et al. Cytotoxicity-dependent APO-1 (Fas/CD95) associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579–5588 (1995).

    Article  CAS  Google Scholar 

  6. Zhang, J. & Winoto, A. Amouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis. Mol. Cell. Biol. 16, 2756–2763 (1996).

    Article  CAS  Google Scholar 

  7. Muzio, M.et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817–827 (1996).

    Article  CAS  Google Scholar 

  8. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V. & Wallach, D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 85, 803–815 (1996).

    Article  CAS  Google Scholar 

  9. Chinnaiyan, A. M.et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961–4965 (1996).

    Article  CAS  Google Scholar 

  10. Hsu, H., Shu, H.-B., Pan, M.-G. & Goeddel, D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299–308 (1996).

    Article  CAS  Google Scholar 

  11. Bodmer, J.-L.et al. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6, 79–88 (1997).

    Article  CAS  Google Scholar 

  12. Chinnaiyan, A. M.et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990–992 (1996).

    Article  ADS  CAS  Google Scholar 

  13. Kitson, J.et al. Adeath-domain-containing receptor that mediates apoptosis. Nature 384, 372–375 (1996).

    Article  ADS  CAS  Google Scholar 

  14. Marsters, S. A.et al. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB. Curr. Biol. 6, 1669–1676 (1996).

    Article  CAS  Google Scholar 

  15. Yang, X., Khosravi-Far, R., Chang, H. Y. & Baltimore, D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067–1076 (1997).

    Article  CAS  Google Scholar 

  16. Chen, J., Lansford, R., Stewart, V., Young, F. & Alt, F. W. RAG-2-deficient blastoyst complementation: An assay of gene function in lymphocyte development. Proc. Natl Acad. Sci. USA 90, 4528–4532 (1993).

    Article  ADS  CAS  Google Scholar 

  17. Mortensen, R. M., Conner, D. A., Chao, S., Geisterfer-Lowrance, A. A. & Seidman, J. G. Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell. Biol. 12, 2391–2395 (1992).

    Article  CAS  Google Scholar 

  18. Mombaerts, P.et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869–877 (1992).

    Article  CAS  Google Scholar 

  19. Chu, K., Niu, X. & Williams, L. T. AFas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc. Natl Acad. Sci. USA 92, 11894–11898 (1995).

    Article  ADS  CAS  Google Scholar 

  20. Sato, T., Irie, S., Kitada, S. & Reed, J. C. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268, 411–415 (1995).

    Article  ADS  CAS  Google Scholar 

  21. Stanger, B. Z., Leder, P., Lee, T.-H., Kim, E. & Seed, B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (D95) in yest and causes cell death. Cell 81, 513–523 (1995).

    Article  CAS  Google Scholar 

  22. Ogasawara, J., Suda, T. & Nagata, S. Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J. Exp. Med. 181, 485–491 (1995).

    Article  CAS  Google Scholar 

  23. Hernandez-Caselles, T. & Stutman, O. Immune functions of tumor necrosis factor. J. Immunology 151, 3999–4012 (1993).

    CAS  Google Scholar 

  24. Suzuki, H.et al. Derugulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268, 1472–1476 (1995).

    Article  ADS  CAS  Google Scholar 

  25. Fournel, S., Genestier, L., Robinet, E., Flacher, M. & Revillard, J.-P. Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. J. Immunol. 157, 4309–4315 (1996).

    CAS  PubMed  Google Scholar 

  26. Lenardo, M. J. The molecular regulation of lymphocyte apoptosis. Semin. Immunol. 9, 1–5 (1997).

    Article  CAS  Google Scholar 

  27. Parijs, L. V.et al. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor1. J. Immunol. 158, 3738–3745 (1997).

    PubMed  Google Scholar 

  28. Lenardo, M. J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353, 858–861 (1991).

    Article  ADS  CAS  Google Scholar 

  29. Ramirez-Solis, R., Davis, A. C. & Bradley, A. Gene targeting in embryonic stem cells. Methods Enzymol. 225, 855–878 (1993).

    Article  CAS  Google Scholar 

  30. Schmid, I., Uittenbogaart, C. H., Keld, B. & Giorgi, J. V. Arapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol. Methods 170, 145–157 (1994).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank members of the Winoto, Allison, Robey and Raulet groups for discussions; P. Schow for technical assistance; A. Nagy, R. Nagy and W. Abramow-Newerly for the R1 ES cells; R.Jaenisch for the J1 ES cells; and E. Robey, B. Ortiz and H. Kasler for critical reading of the manuscript. This work is supported in part by grants from the NIH, National Science foundation and the Keck Foundation. J.Z. was supported by an Irvington Institute fellowship and is a Leukemia Society of America special fellow.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Astar Winoto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, J., Cado, D., Chen, A. et al. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392, 296–300 (1998). https://doi.org/10.1038/32681

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/32681

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing